Mixed options sentiment in Pfizer (PFE), with shares down 2c near $25.64. Options volume roughly in line with average with 61k contracts traded and calls leading puts for a put/call ratio of 0.47, compared to a typical level near 0.56. Implied volatility (IV30) dropped 0.46 near 22.23,in the bottom quartile of the past year, suggesting an expected daily move of $0.36. Put-call skew steepened, indicating increased demand for downside protection.Looking ahead: Pfizer (PFE) will report earnings before the open on 2026-02-03.Option markets are pricing in a 50% probability of a move greater than 1.88% or $0.48.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s New Autoimmune Candidate PF-08065010 Enters Phase 1: What Investors Should Watch
- Pfizer Takes Aim at Keytruda in New Phase 3 Lung Cancer Study: What Investors Should Know
- Pfizer Advances New COPD Candidate Into Phase 2/3, Adding Depth to Its Post-COVID Pipeline
- Novo Nordisk Stock (NVO) Gains on Obesity Pill Demand as Goldman Flags Earnings Upside
- Pfizer Advances PF-07248144 With New Drug–Interaction Study, Signaling Quiet Pipeline Progress